We previously demonstrated that MEK/ERK activity is sufficient to induce p21CIP1 [36] and that the MEK/ERK activity in BRAF-mutant tumor cells can be routed to induce p21CIP1 expression [37]. The gene discussed is CDKN1A; the disease is neoplasm.